Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-13 Sale | 2022-09-15 7:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 245,039 | $23.76 | $5,823,084 | 9,418,606 (Direct) | View |
| 2022-09-02 Sale | 2022-09-15 1:21 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 5,000 | $23.82 | $119,108 | 10,103,365 (Indirect) | View |
| 2022-09-01 Sale | 2022-09-06 7:54 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $23.25 | $232,484 | 314,401 (Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:52 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 5,000 | $23.27 | $116,358 | 10,108,365 (Indirect) | View |
| 2022-09-01 Sale | 2022-09-06 7:51 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $23.25 | $232,452 | 2,289,338 (Indirect Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:50 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $23.25 | $290,581 | 1,803,523 (Indirect Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:49 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $23.25 | $290,581 | 1,803,523 (Indirect Direct) | View |
| 2022-08-16 Sale | 2022-08-17 7:25 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 941 | $24.31 | $22,876 | 2,314,777 (Indirect Direct) | View |
| 2022-08-16 Sale | 2022-08-17 7:24 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 4,003 | $24.31 | $97,313 | 1,862,337 (Indirect Direct) | View |
| 2022-08-16 Sale | 2022-08-17 7:23 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 1,089 | $24.31 | $26,474 | 342,276 (Direct) | View |
| 2022-08-04 Sale | 2022-08-08 8:03 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 10,000 | $20 | $200,004 | 10,113,365 (Indirect) | View |
| 2022-08-04 Sale | 2022-08-05 5:20 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $20.05 | $200,541 | 321,365 (Direct) | View |
| 2022-08-04 Sale | 2022-08-05 5:19 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $20 | $250,021 | 1,809,340 (Indirect Direct) | View |
| 2022-08-01 Sale | 2022-08-03 6:57 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $16.88 | $168,810 | 2,296,718 (Indirect Direct) | View |
| 2022-07-18 Sale | 2022-07-20 6:18 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 2,500 | $20 | $50,000 | 331,365 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 6:17 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 2,600 | $20 | $52,001 | 10,123,365 (Indirect) | View |
| 2022-07-18 Sale | 2022-07-20 6:17 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 2,600 | $20 | $52,003 | 1,821,840 (Indirect Direct) | View |
| 2022-07-01 Sale(A) | 2022-07-12 9:14 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 1,800 | $20 | $36,000 | 10,127,207 (Indirect) | View |
| 2022-07-08 Sale | 2022-07-12 7:52 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 1,242 | $20 | $24,840 | 10,125,965 (Indirect) | View |
| 2022-07-08 Sale | 2022-07-12 7:31 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 1,416 | $20 | $28,320 | 333,865 (Direct) | View |
| 2022-07-08 Sale | 2022-07-12 7:30 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 1,795 | $20 | $35,900 | 1,824,440 (Indirect Direct) | View |
| 2022-07-01 Sale | 2022-07-06 9:00 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 2,279 | $20 | $45,580 | 335,281 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 8:58 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 1,800 | $20 | $36,000 | 463,200 (Indirect) | View |
| 2022-07-01 Sale | 2022-07-06 8:57 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $18.72 | $187,158 | 2,306,718 (Indirect Direct) | View |
| 2022-07-01 Sale | 2022-07-06 8:56 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 2,603 | $20 | $52,060 | 1,826,235 (Indirect Direct) | View |
| 2022-06-17 Purchase | 2022-06-22 5:09 pm | Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Opportunity Fund II L.P. Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 766,667 | $15 | $11,500,005 | 8,984,019 (Indirect Direct) | View |
| 2022-06-17 Purchase | 2022-06-22 4:47 pm | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 766,667 | $15 | $11,500,005 | 766,667 (Indirect) | View |
| 2022-06-17 Purchase | 2022-06-21 4:37 pm | Day One Biopharmaceuticals Inc. | DAWN | AI Day1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 1,200,000 | $15 | $18,000,000 | 10,684,638 (Direct) | View |
| 2022-06-15 Sale | 2022-06-17 9:47 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 50,000 | $16.26 | $813,155 | 2,316,718 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-12 Option Award | 2022-09-14 7:34 pm | N/A 2032-09-11 | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 33,900 | $0 | 33,900 (Direct) | View |
Ownership | 2022-09-14 7:32 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 0 | $0 | 0 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 7:25 pm | N/A 2032-01-17 | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 3,561 | $0 | 2,314,777 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 7:24 pm | N/A 2032-01-17 | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 10,686 | $0 | 1,862,337 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 7:23 pm | N/A 2032-01-17 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 4,125 | $0 | 342,276 (Direct) | View |
Ownership | 2022-07-12 9:14 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 0 | $0 | 10,129,007 (Indirect) | View |
| 2021-11-03 Ownership | 2022-07-12 9:14 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 465,000 | $0 | 10,129,007 (Direct) | View |
| 2022-07-01 Other | 2022-07-06 4:42 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Opportunity Fund I L.P. 10% Owner | 198,280 | $0 | 991,396 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 8:27 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 28,700 | $0 | 28,700 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 6:12 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director | 28,700 | $0 | 28,700 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 6:11 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director | 28,700 | $0 | 28,700 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 6:11 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 28,700 | $0 | 28,700 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 6:10 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 28,700 | $0 | 28,700 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 6:09 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 28,700 | $0 | 28,700 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 6:08 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director | 28,700 | $0 | 28,700 (Direct) | View |